2024 Transferred values declared to VVKT

Transferred values

2024 Disclosing Reports for transfered values

AbbVie, UAB

2025-07-01

AstraZeneca Lietuva, UAB

2025-07-01

Bayer, UAB

2025-07-01

Biogen Lithuania, UAB

2025-07-01

Boehringer Ingelheim RCV GmbH & Co KG Lietuvos filialas

2025-07-01

Egis Pharmaceuticals PLC atstovybė Lietuvoje

2025-07-01

Grindeks, AB filialas / Grindeks Kalceks Lietuva, UAB

2025-06-30

Merck Sharp & Dohme, UAB

2025-07-01

Mylan Healthcare, UAB

2025-06-30

Novo Nordisk Pharma, UAB

2025-07-01

Pfizer Luxembourg SARL filialas

2025-07-01

Servier Pharma, UAB

2025-06-30

Takeda, UAB

2025-07-01

Teva Baltics, UAB

2025-06-30

Companies that had no transferred values during year 2024

Gedeon Richter Plc. atstovybė Lietuvoje

Disclosure reports of 2023 transfers of value

Disclosure reports of 2022 transfers of value

Disclosure reports of 2021 transfers of value

Disclosure reports of 2020 transfers of value

Disclosure reports of 2019 transfers of value

Disclosure reports of 2018 transfers of value

Disclosure reports of 2017 transfers of value

Disclosure reports of 2016 transfers of value

Disclosure reports of 2015 transfers of value